SCHEMBL13961465

SCHEMBL13961465

COBN1CCN(c2ccncc2NC(=O)c2ccnc(-c3cccnc3)n2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 6/20 0.48
GSK3B P49841 5/20 0.48
PIM3 Q86V86 4/20 0.44
PIM2 Q9P1W9 4/20 0.44
PIM1 P11309 3/20 0.44
CHEK1 O14757 3/20 0.43
ATR Q13535 1/20 0.42
CYP1A2 P05177 2/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
PPARG P37231 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NR2E3 Q9Y5X4 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13961713 0.89 PIM2 (0.48) GSK3AGSK3BPIM3PIM2PIM1
SCHEMBL13961448 0.89 GSK3B (0.50) GSK3AGSK3BPIM3PIM2PIM1
SCHEMBL13961456 0.88 GSK3B (0.47) GSK3AGSK3BPIM3PIM2PIM1
SCHEMBL13961461 0.88 GSK3B (0.44) GSK3AGSK3BPIM3PIM2PIM1
SCHEMBL13961453 0.88 CHEK1 (0.56) GSK3AGSK3BPIM3PIM2PIM1
SCHEMBL13961486 0.87 GSK3A (0.46) GSK3AGSK3BPIM3PIM2PIM1
SCHEMBL13961709 0.87 GSK3B (0.46) GSK3AGSK3BPIM3PIM2PIM1
SCHEMBL13961607 0.87 GSK3B (0.46) GSK3AGSK3BPIM3PIM2PIM1
SCHEMBL13961445 0.87 WDR5 (0.45) GSK3AGSK3BPIM3PIM2PIM1
SCHEMBL13961468 0.86 CHEK1 (0.57) GSK3AGSK3BPIM3PIM2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009014637-A2 HETEROCYCLIC AMIDE COMPOUNDS AS PROTEIN KINASE INHIBITORS SCHERING CORPORATION (US) 2009-01-29 WO disclosed